|
Charles W. Mango, M.D.
Curriculum Vitae
Updated May 2007
Address: Retina Consultations - 915 Palmer Rd - Bronxville, NY - 10708
Phone: 914.793.6900
Email: contact@retinaconsultations.com
OCCUPATION
Sept 2006-Present
- Retina Consultations - Private Ophthalmology Practice
- Cornell University - New York Presbyterian Hospital - Clinical Assistant Professor of Ophthalmology
EDUCATION & TRAINING
Jul 2004-Jul 2006
- University of California Los Angeles - Jules Stein Eye Institute Los Angeles, CA
- Fellow of Vitreoretinal Surgery, Department of Ophthalmology
Jul 2001-Jun 2004
- Cornell University - New York Presbyterian Hospital New York, NY
- Resident Physician, Department of Ophthalmology
Jul 2000-Jun 2001
- St. Joseph’s Hospital Health Center Syracuse, NY
- Resident Physician, Transitional Year Program
Jul 1996-May 2000
- State University of New York - Upstate Medical University Syracuse, NY
- Doctor of Medicine
- Medical Student Research Program Participant
Sep 1992-May1996
- State University of New York - Binghamton University Binghamton, NY
- Bachelor of Science in Biology
- Magna Cum Laude Graduate
AWARDS & HONORS
2004-2005 Fellowship
- Harold and Pauline Price Fellow Scholarship in Vitreoretinal Surgery
- Rosalind Alcott Fellow Scholarship in Vitreoretinal Surgery
2003-2004 Residency
- Co-Chief Resident of Ophthalmology
- Aravind Eye Hospital Mission - South East India
1996-2000 Medical School
- Alpha Omega Alpha Medical Honor Society
- Merck Manual Award for Outstanding Academic Achievement
1992-1996 Undergraduate
- Magna Cum Laude Graduate
- Phi Beta Kappa Honor Society
CURRENT ACADEMIC APPOINTMENTS
Sep 2006-Present
- Cornell University – Weill Medical Center - New York, NY
- Clinical Assistant Professor of Ophthalmology
CURRENT HOSPITAL APPOINTMENTS
Sep 2006-Present
- Lawrence Hospital Center - Bronxville, NY
- Attending Physician, Department of Ophthalmology
Sep 2006-Present
- New York Presbyterian Hospital - New York, NY
- Attending Physician, Department of Ophthalmology
TEXTBOOK CHAPTERS
Diabetic Retinopathy
C.W. Mango, A. Gupta
Educational Review Manual in Endocrinology, Diabetes and Metabolism, 4th edition
Castle Conolly Graduate Medical Publishing, New York. 2006
Choroidal Folds
C.W. Mango, D. Sarraf, S. Schwartz
Essentials in Ophthalmology: Medical Treatment of the Retina
Springer-Verlag, Heidelberg. 2005. Chapter 5 (65-76)
PRESENTATIONS & PUBLICATIONS
May 2007 Ultrawidefield Imaging and Angiography of Retinal Dystrophies
C.W. Mango, A. Gupta, D. Sarraf, I. Suner, T. Friberg, S.D. Schwartz
Jules Stein Eye Institute / UCLA, Los Angeles, CA
Association for Research in Vision and Ophthalmology, Paper presentation for May 2007
Jan 2007 Robotic Ocular Surgery
A. Tsirbias, C.W. Mango, E. Dutson
Br J Ophthalmol. 2007 Jan; 91(1) 18-21
Nov 2006 Systemic Risk Factors for the Progression of Laser Treated Retinopathy of Prematurity to Stage 4 or 5 Disease
D. Bourla, C. Gonzales, C.W. Mango, S.D. Schwartz
Jules Stein Eye Institute / UCLA, Los Angeles, CA
American Academy of Ophthalmology, Poster Presentation
Apr 2005 25-Gauge Transconjunctival Vitrectomy Safety: Post-operative Complications
C.W. Mango, A.Gupta, C.S. Chen, L.Savar, C.R. Gonzales, D.Telander, R.Wirthlin, A.E. Kreiger, S.D. Schwartz.
Jules Stein Eye Institute / UCLA, Los Angeles, CA
Association for Research in Vision and Ophthalmology, poster presentation
Apr 2005 Peripheral Retinal Ischemia Associated With Diffuse Diabetic Macular Edema Identified With Widefield Angiography
S.D. Schwartz, A.Gupta, C.R. Gonzales, T.A. Young, D.Telander, C.W.Mango, R.Wirthlin, A.E. Kreiger
Jules Stein Eye Institute / UCLA, Los Angeles, CA
Association for Research in Vision and Ophthalmology, paper presentation
Apr 2005 Peripheral Angiographic Evaluation of Vitreoretinal Diseases Using the Optos Panoramic200A™ Imaging System
C.R. Gonzales, A.Gupta, T.A. Young, D.Telander, C.W.Mango, R.Wirthlin, A.E. Kreiger, S.D. Schwartz
Jules Stein Eye Institute / UCLA, Los Angeles, CA
Association for Research in Vision and Ophthalmology, poster presentation
Apr 2005 Evaluation of Choroidal Lesions in an Oncology Practice: Peripheral Angiography Using the Optos Panoramic200A™ Imaging System
T.A. Young, A.Gupta, C.R. Gonzales, C.W.Mango, R.Wirthlin, A.E. Kreiger, S.D. Schwartz
Jules Stein Eye Institute / UCLA, Los Angeles, CA
Association for Research in Vision and Ophthalmology, poster presentation
Apr 2005 25-Gauge Transconjunctival Vitrectomy: Intraoperative Safety
C.S. Chen1, A.Gupta1, L.Savar2, C.Gonzales1, D.Telander1, C.W.Mango1, R.Wirthlin1, A.E. Kreiger1, S.D. Schwartz1
1Jules Stein Eye Institute / UCLA, Los Angeles, CA
2University of California, San Francisco, San Francisco, CA.
Association for Research in Vision and Ophthalmology, poster presentation
Apr 2005 25-Gauge Transconjunctival Vitrectomy Safety: Cataract Progression
A.Gupta1, C.S. Chen1, L.Savar2, C.Gonzales1, D.Telander1, C.W.Mango1, R.Wirthlin1, A.E. Kreiger1, S.D. Schwartz1
1Jules Stein Eye Institute / UCLA, Los Angeles, CA
2University of California, San Francisco, San Francisco, CA.
Association for Research in Vision and Ophthalmology, poster presentation
Nov 2004 The Patient Who Defied All Odds - Trisomy 13 Case Report
C.W. Mango1, D.H. Abramson2
1Jules Stein Eye Institute / UCLA, Los Angeles, CA
2Memorial Sloan-Kettering Cancer Center, New York, NY
American Academy of Ophthalmology, EyeNet Nov 2004:43-44
Oct 2003 Macular Hole Surgery Outcomes with Perfluoron Liquid Assisted Internal Limiting Membrane Removal
C.W. Mango, V. Reppucci
Weill Medical College of Cornell University/ New York Presbyterian Hospital
American Academy of Ophthalmology, poster presentation
Aug 2003 Macular Hole Surgery Procedure and Outcomes using Perfluoron Liquid Assisted Internal Limiting Membrane Removal
V. Reppucci, C.W. Mango
Weill Medical College of Cornell University/ New York Presbyterian Hospital
American Society of Retina Specialists, paper presentation
CLINICAL TRIALS
Primary Investigator
Genentech FVF4168g & FVF4170g: A Phase III, Multicenter, Randomized, Sham-Controlled Study of the Efficacy and Safety of Ranibizumab Compared to Laser Photocoagulation In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Sub-Investigator
Eyetech EOP1004G: A Phase II/III Randomized, Double-Masked, Controlled, Dose-Ranging, Multi-Center Comparative Trial, in Parallel Groups, to Establish the Safety and Efficacy of Intravitreal Injections of EYE001 (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks for 54 Weeks, in Patients with Exudative Age-Related Macular Degeneration (AMD)
Sub-Investigator
Eyetech EOP 1006: A Randomized, Double-Masked, Multi-Center Trial of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Intravitreal Injections of Pegaptanib Sodium (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks for 54 Weeks in Patients with Exudative Age-Related Macular Degeneration (AMD)
Sub-Investigator
Eyetech EOP1009: A Phase II Prospective, Randomized, Double-Masked, Sham-Controlled, Dose-Ranging, Multi-center Trial to Assess the Effect of Pegaptanib Sodium on Foveal Thickening in Patients with Exudative Subfoveal Age Related Macular Degeneration (AMD)
Sub-Investigator
Eyetech EOP1010: An Open Label, Non-Comparative Protocol for the Use of Pegaptanib Sodium Injection Every 6 Weeks in Patients with Exudative Age-Related Macular Degeneration (AMD)
Sub-Investigator
Eyetech EOP 1011: A Phase II Randomized, Dose-Ranging, Double-Masked, Multi-Center Trial, in Parallel Groups, to Determine the Safety, Efficacy and Pharmacokinetics of Intravitreous Injections of Pegaptanib Sodium Compared to Sham Injection for 30 Weeks in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion
Sub-Investigator
Eyetech EOP 1012B: A Phase IV, Randomized, Active Controlled, Double-Masked, Single Dummy, Multi-Center Comparative Trial, in Parallel Groups, to Compare the Safety and Efficacy of Intravitreous Injections of Pegaptanib Sodium Given Every 6 Weeks for up to 102 Weeks, Plus Sham Photodynamic Therapy (PDT), to Pegaptanib Sodium Plus PDT with Visudyne, in Subjects with Predominantly Classic Subfoveal Choroidal Neovasculariztion (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Sub-Investigator
Eyetech EOP 1013: A Phase II/III Randomized, Controlled, Double-Masked, Multi-Center, Comparative Dose-Finding Trial, in Parallel Groups, to Compare the Safety and Efficacy of Intravitreous Injections of 0.3, 0.03 or 0.003 mg Pegaptanib Sodium, Given as Often as Every 6 Weeks for 3 years, to Sham Injections, in Subjects with Diabetic Macular Edema (DME) Involving the Center of the Macula
Sub-Investigator
Alcon C-03-15: An Open Label Evaluation of Long Term Efficacy and Safety of Posterior Juxtascleral Injections of Anecortave Acetate 15 mg in patients with Subfoveal Exudative Age-Related Macular Degeneration (AMD) Who were Enrolled in Alcon Study C-98-03
Sub-Investigator
SCORE Study: Two Randomized Trials to Compare the Efficacy and Safety of Intravitreal Injection(s) of Triamcinolone Acetonide with Standard Care to Treat Macular Edema: One for Central Retinal Vein Occlusion and One for Branch Retinal Vein Occlusion
Sub-Investigator
Allergan 206207008 - 6 month, phase III, Multicenter, Masked, Randomized, Sham-controlled Trial to Assess the Safety and Efficacy of 700 ug and 350 ug of Dexamethasone Posterior Segment Drug Delivery System in the Treatment of Patients with Macular Edema Following Central Retinal Vein Occlusion or Branch Retinal Vein Occlusion
Sub-Investigator
Allergan 206207011-3 yr. phase III, Multicenter, Masked, Randomized, Sham-controlled Trial to Assess the Safety and Efficacy of 700 ug and 350 ug Posterior Segment Drug Delivery System in the Treatment of Patients with Diabetic Macular Edema
MEDICAL LICENSURE & BOARDS CERTIFICATION
2006 American Board of Ophthalmology
2003 California Medical License
2000 New York Medical License
2000 Drug Enforcement Agency
SOCIETY MEMBERSHIPS
2006-Present American Society of Retina Specialists, Member
2001-Present American Academy of Ophthalmology, Member
2001-Present Association for Research in Vision and Ophthalmology, Member
2001-Present New York State Ophthalmological Society, Member
2000-Present American Medical Association, Member
HONOR SOCIETY MEMBERSHIPS
2000-Present Alpha Omega Alpha Medical Honor Society
1996-Present Phi Beta Kappa Honor Society
OTHER EXPERIENCE
2006-Present
- Section Editior of "Retina Times"
- Quarterly publication of the American Society of Retina Specialists
1999-Present
- Cornell University EsBaran Field Laboratory
- Partner
- Research facility in the Amazon rainforest dedicated to education, conservation, and the discovery of novel medicinal compounds
|
